 Maria Cavasin
Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Remodeling | 13 | 2021 | 229 | 1.500 |
Why?
| | Histone Deacetylases | 7 | 2018 | 198 | 1.010 |
Why?
| | Myocardial Infarction | 8 | 2022 | 968 | 0.840 |
Why?
| | Oligopeptides | 5 | 2010 | 252 | 0.840 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2021 | 146 | 0.810 |
Why?
| | Histone Deacetylase Inhibitors | 6 | 2021 | 200 | 0.730 |
Why?
| | Myocardium | 14 | 2022 | 970 | 0.700 |
Why?
| | Hypertension, Pulmonary | 5 | 2021 | 1794 | 0.590 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2014 | 36 | 0.510 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.500 |
Why?
| | Angiotensin II | 7 | 2021 | 107 | 0.490 |
Why?
| | Rats | 17 | 2022 | 5392 | 0.460 |
Why?
| | Heart | 4 | 2007 | 631 | 0.440 |
Why?
| | Rats, Sprague-Dawley | 11 | 2019 | 2478 | 0.440 |
Why?
| | Myocytes, Cardiac | 9 | 2022 | 472 | 0.420 |
Why?
| | Cardiomegaly | 4 | 2016 | 168 | 0.400 |
Why?
| | Cell Proliferation | 4 | 2021 | 2275 | 0.400 |
Why?
| | Testosterone | 2 | 2005 | 351 | 0.380 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2021 | 454 | 0.380 |
Why?
| | Endothelin Receptor Antagonists | 1 | 2010 | 59 | 0.370 |
Why?
| | Heart Ventricles | 6 | 2021 | 727 | 0.370 |
Why?
| | Blood Pressure | 9 | 2018 | 1664 | 0.350 |
Why?
| | Thymosin | 2 | 2006 | 5 | 0.340 |
Why?
| | Animals | 34 | 2022 | 33381 | 0.340 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2004 | 195 | 0.330 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 245 | 0.320 |
Why?
| | Hemodynamics | 3 | 2018 | 1004 | 0.320 |
Why?
| | Vascular Remodeling | 2 | 2021 | 152 | 0.310 |
Why?
| | Heart Failure | 6 | 2022 | 1969 | 0.310 |
Why?
| | Serine Endopeptidases | 2 | 2007 | 105 | 0.310 |
Why?
| | Fibrosis | 7 | 2022 | 483 | 0.300 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2007 | 39 | 0.290 |
Why?
| | Kidney | 4 | 2007 | 1353 | 0.260 |
Why?
| | Transcription Factors | 3 | 2019 | 1570 | 0.260 |
Why?
| | Mice | 20 | 2022 | 15520 | 0.250 |
Why?
| | Kidney Cortex | 1 | 2004 | 31 | 0.250 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2018 | 374 | 0.240 |
Why?
| | Antihypertensive Agents | 3 | 2010 | 437 | 0.230 |
Why?
| | Disease Models, Animal | 10 | 2021 | 3730 | 0.230 |
Why?
| | Pulmonary Artery | 2 | 2021 | 1063 | 0.230 |
Why?
| | Collagen | 7 | 2007 | 433 | 0.210 |
Why?
| | Myofibrils | 1 | 2022 | 50 | 0.210 |
Why?
| | Sarcomeres | 1 | 2022 | 91 | 0.210 |
Why?
| | Ramipril | 2 | 2001 | 4 | 0.210 |
Why?
| | Liver | 1 | 2010 | 1816 | 0.210 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2021 | 236 | 0.210 |
Why?
| | Tetrazoles | 2 | 2001 | 32 | 0.200 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 122 | 0.200 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.200 |
Why?
| | Heart Murmurs | 1 | 2021 | 12 | 0.200 |
Why?
| | Angiotensin I | 1 | 2000 | 4 | 0.190 |
Why?
| | Mice, Inbred C57BL | 9 | 2019 | 4908 | 0.190 |
Why?
| | Imidazoles | 2 | 2001 | 232 | 0.180 |
Why?
| | Extracellular Matrix | 2 | 2021 | 446 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2022 | 4077 | 0.180 |
Why?
| | Estradiol | 1 | 2003 | 476 | 0.180 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 527 | 0.180 |
Why?
| | Regional Blood Flow | 2 | 2012 | 418 | 0.170 |
Why?
| | Male | 22 | 2021 | 57801 | 0.170 |
Why?
| | Cardiomyopathies | 1 | 2022 | 299 | 0.160 |
Why?
| | Thermogenesis | 1 | 2018 | 43 | 0.160 |
Why?
| | Myofibroblasts | 1 | 2019 | 120 | 0.160 |
Why?
| | Hypertension | 4 | 2011 | 1203 | 0.160 |
Why?
| | Drug Discovery | 2 | 2016 | 124 | 0.160 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 71 | 0.160 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 122 | 0.150 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 404 | 0.140 |
Why?
| | Tryptophan Hydroxylase | 1 | 2016 | 52 | 0.140 |
Why?
| | Hypoxia | 2 | 2013 | 963 | 0.140 |
Why?
| | Fatty Liver | 1 | 2018 | 253 | 0.140 |
Why?
| | Chromatin | 1 | 2019 | 441 | 0.130 |
Why?
| | Enzyme Inhibitors | 3 | 2016 | 827 | 0.130 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 257 | 0.130 |
Why?
| | Protease Inhibitors | 2 | 2007 | 102 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2019 | 597 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 709 | 0.130 |
Why?
| | Fibroblasts | 2 | 2022 | 842 | 0.120 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 29 | 0.120 |
Why?
| | Captopril | 2 | 2004 | 12 | 0.120 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2004 | 56 | 0.120 |
Why?
| | Ovariectomy | 2 | 2005 | 124 | 0.120 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2004 | 127 | 0.120 |
Why?
| | Mice, Knockout | 6 | 2021 | 2680 | 0.120 |
Why?
| | Muscular Atrophy | 1 | 2014 | 80 | 0.120 |
Why?
| | Adenylate Kinase | 1 | 2013 | 29 | 0.110 |
Why?
| | Histone Deacetylase 6 | 3 | 2022 | 19 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 241 | 0.110 |
Why?
| | Calcinosis | 1 | 2014 | 282 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2014 | 241 | 0.100 |
Why?
| | Benzamides | 1 | 2012 | 176 | 0.100 |
Why?
| | Portal Pressure | 1 | 2010 | 6 | 0.090 |
Why?
| | Hepatic Stellate Cells | 1 | 2010 | 10 | 0.090 |
Why?
| | Connectin | 2 | 2022 | 26 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 703 | 0.090 |
Why?
| | Receptor, Endothelin B | 1 | 2010 | 53 | 0.090 |
Why?
| | Receptor, Endothelin A | 1 | 2010 | 60 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 371 | 0.090 |
Why?
| | Hypertension, Portal | 1 | 2010 | 67 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2445 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2013 | 726 | 0.090 |
Why?
| | Piperidines | 1 | 2010 | 171 | 0.080 |
Why?
| | Pyrimidines | 1 | 2012 | 382 | 0.080 |
Why?
| | Nephrosclerosis | 1 | 2008 | 6 | 0.080 |
Why?
| | Endothelin-1 | 1 | 2010 | 168 | 0.080 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 45 | 0.080 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 260 | 0.080 |
Why?
| | Pyridines | 1 | 2012 | 440 | 0.080 |
Why?
| | Macrophages | 5 | 2008 | 1324 | 0.080 |
Why?
| | Heart Rate | 4 | 2007 | 729 | 0.080 |
Why?
| | Histones | 1 | 2013 | 552 | 0.080 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 589 | 0.080 |
Why?
| | Indoles | 2 | 2014 | 316 | 0.080 |
Why?
| | Glomerular Mesangium | 1 | 2007 | 19 | 0.080 |
Why?
| | Random Allocation | 2 | 2008 | 344 | 0.080 |
Why?
| | Arginine Vasopressin | 1 | 2007 | 47 | 0.080 |
Why?
| | Stroke Volume | 3 | 2014 | 513 | 0.080 |
Why?
| | Substance P | 1 | 2007 | 44 | 0.070 |
Why?
| | Heart Function Tests | 2 | 2004 | 61 | 0.070 |
Why?
| | Sulfonamides | 1 | 2010 | 445 | 0.070 |
Why?
| | Heart Rupture | 2 | 2004 | 4 | 0.070 |
Why?
| | Chronic Disease | 2 | 2004 | 1636 | 0.070 |
Why?
| | Azepines | 2 | 2019 | 74 | 0.070 |
Why?
| | Time Factors | 5 | 2014 | 6412 | 0.070 |
Why?
| | Case-Control Studies | 3 | 2021 | 3171 | 0.070 |
Why?
| | Castration | 1 | 2005 | 14 | 0.070 |
Why?
| | Female | 9 | 2021 | 61565 | 0.070 |
Why?
| | Hydroxamic Acids | 2 | 2018 | 80 | 0.070 |
Why?
| | Ventricular Function, Left | 2 | 2014 | 468 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2017 | 290 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 576 | 0.070 |
Why?
| | Rupture | 1 | 2005 | 105 | 0.070 |
Why?
| | Triazoles | 2 | 2019 | 134 | 0.070 |
Why?
| | Obesity | 1 | 2018 | 2746 | 0.070 |
Why?
| | Hydroxyproline | 1 | 2004 | 24 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1489 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2019 | 539 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1515 | 0.060 |
Why?
| | Thiazolidines | 1 | 2004 | 7 | 0.060 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 97 | 0.060 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2004 | 3 | 0.060 |
Why?
| | Growth Inhibitors | 1 | 2004 | 43 | 0.060 |
Why?
| | Dipeptides | 1 | 2004 | 51 | 0.060 |
Why?
| | Proline | 1 | 2004 | 71 | 0.060 |
Why?
| | Thiazoles | 1 | 2004 | 121 | 0.060 |
Why?
| | Humans | 12 | 2022 | 118974 | 0.060 |
Why?
| | Organ Specificity | 1 | 2004 | 278 | 0.060 |
Why?
| | Nitriles | 1 | 2004 | 155 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1715 | 0.060 |
Why?
| | Nephrectomy | 1 | 2004 | 162 | 0.060 |
Why?
| | Orchiectomy | 1 | 2003 | 57 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2022 | 154 | 0.050 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 164 | 0.050 |
Why?
| | Elastic Modulus | 1 | 2022 | 118 | 0.050 |
Why?
| | Receptors, Bradykinin | 1 | 2001 | 4 | 0.050 |
Why?
| | Acute Disease | 1 | 2004 | 940 | 0.050 |
Why?
| | Microscopy, Atomic Force | 1 | 2022 | 118 | 0.050 |
Why?
| | Survival Rate | 1 | 2005 | 1720 | 0.050 |
Why?
| | Cytoprotection | 1 | 2001 | 55 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2013 | 345 | 0.050 |
Why?
| | Protein Binding | 2 | 2019 | 1975 | 0.050 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 462 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2001 | 84 | 0.050 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 122 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2022 | 306 | 0.050 |
Why?
| | Cardiac Output | 1 | 2000 | 147 | 0.050 |
Why?
| | Sex Factors | 1 | 2005 | 1781 | 0.050 |
Why?
| | Body Weight | 1 | 2004 | 934 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 277 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2004 | 671 | 0.040 |
Why?
| | Organ Size | 1 | 2000 | 460 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1012 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 292 | 0.040 |
Why?
| | Systole | 2 | 2014 | 168 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 892 | 0.040 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 152 | 0.040 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 180 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 285 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 35 | 0.040 |
Why?
| | Echocardiography | 1 | 2000 | 556 | 0.040 |
Why?
| | Myosins | 1 | 2018 | 130 | 0.040 |
Why?
| | Inflammation | 2 | 2008 | 2566 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2014 | 965 | 0.040 |
Why?
| | Signal Transduction | 3 | 2017 | 4709 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2018 | 247 | 0.040 |
Why?
| | RNA Polymerase II | 1 | 2019 | 282 | 0.040 |
Why?
| | Isoenzymes | 1 | 2017 | 297 | 0.040 |
Why?
| | Molecular Imaging | 1 | 2016 | 54 | 0.030 |
Why?
| | Hydrogels | 1 | 2022 | 582 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 80 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 806 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
| | Serotonin | 1 | 2016 | 309 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 23 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 29 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 625 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 90 | 0.030 |
Why?
| | Simvastatin | 1 | 2014 | 65 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 756 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 502 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 307 | 0.030 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 44 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 767 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 136 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.030 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 1798 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 550 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 345 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 607 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 191 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1085 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1180 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 460 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 564 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2874 | 0.020 |
Why?
| | Probability | 1 | 2008 | 305 | 0.020 |
Why?
| | Albuminuria | 1 | 2008 | 195 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6561 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 774 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1753 | 0.020 |
Why?
| | Middle Aged | 2 | 2018 | 27617 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2007 | 287 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1194 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2008 | 683 | 0.020 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2004 | 48 | 0.020 |
Why?
| | Renal Circulation | 1 | 2004 | 75 | 0.020 |
Why?
| | Connective Tissue Growth Factor | 1 | 2004 | 21 | 0.020 |
Why?
| | Lung | 1 | 2016 | 3664 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 55 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1691 | 0.010 |
Why?
| | Infant | 1 | 2017 | 8293 | 0.010 |
Why?
| | Cell Movement | 1 | 2008 | 896 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2004 | 133 | 0.010 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2004 | 107 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 225 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1795 | 0.010 |
Why?
| | Mast Cells | 1 | 2004 | 115 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2003 | 38 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2003 | 42 | 0.010 |
Why?
| | Diastole | 1 | 2003 | 145 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 369 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 776 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 2025 | 0.010 |
Why?
| | Receptor, Bradykinin B2 | 1 | 2001 | 2 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2001 | 8 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2001 | 22 | 0.010 |
Why?
| | Monocytes | 1 | 2004 | 513 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 405 | 0.010 |
Why?
| | Aged | 1 | 2018 | 19657 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 18480 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1233 | 0.010 |
Why?
| | Child | 1 | 2017 | 19129 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1388 | 0.010 |
Why?
| | Adult | 1 | 2018 | 31512 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 2490 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 3588 | 0.010 |
Why?
|
|
Cavasin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|